Blue Light Cystoscopy

by the MWHC Blog Team
June 1, 2016

Blue Light Cystoscopy: A Better Way to Detect Bladder Cancer

Bladder cancer is the fifth most commonly diagnosed cancer in the United States with a high rate of recurrence. Unfortunately, up to 30% of bladder tumors are overlooked, because they are often too small to see with the standard testing method called cystoscopy.

Fortunately, a new, FDA-approved method now available at MedStar Washington Hospital Center is helping doctors identify bladder tumors earlier thanks to better imaging. The technology is called Blue Light Cystoscopy with Cysview®.

During this test, the patient is given an imaging agent that is absorbed by the cancerous tissue. This causes it to appear fluorescent when exposed to “blue light,” which is created by a special camera and lens. This allows urologists to detect more of the cancer, remove it, and provide treatment to keep it from coming back.

4f759075-white-light-cystoscopy_05v05f05e050008007

WHITE LIGHT CYSTOSCOPY

60e1b61f-blue-light-cystoscopy_06405d05e05000d007

BLUE LIGHT CYSTOSCOPY AS AN ADJUNCT TO WHITE LIGHT 

For more information, or to schedule an appointment, call

202-877-3627

As heard on WTOP Radio:

Lambros Stamatakis MD

Lambros Stamatakis MD
Director, Urologic Oncology
MedStar Washington Hospital Center

Lambros Stamatakis, MD

To schedule an appointment with Dr. Stamatakis, call 202-877-3627

MISSED OUR OTHER TOPICS?

Category: Medical Intel     Tags: medical-intel